Terms: = Testicular cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Prognosis
20 results:
1. Silencing of LINC00467 inhibits cell proliferation in testicular germ cell tumors cells.
Zhu F; Liu Z; Zhou Q; Zhou D; Fan J; Bo H; Fan L
Biomol Biomed; 2023 Sep; 23(5):802-814. PubMed ID: 37078359
[TBL] [Abstract] [Full Text] [Related]
2. TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors.
Bacon JVW; Giannatempo P; Cataldo G; Fazli L; Saxena N; Ozgun G; Soleimani M; Chi K; Nichols C; Necchi A; Wyatt AW; Kollmannsberger CK; Nappi L
Oncologist; 2022 Nov; 27(11):e912-e915. PubMed ID: 36166584
[TBL] [Abstract] [Full Text] [Related]
3. Cytogenetics of spermatocytic tumors with a discussion of gain of chromosome 12p in anaplastic variants.
Gupta S; Farooq A; Rowsey RA; Rahman MA; Shen W; Herrera-Hernandez L; Raghunathan A; Thompson RH; Boorjian SA; Leibovich BC; Cheville JC; Jimenez RE
Hum Pathol; 2022 Jun; 124():85-95. PubMed ID: 35378115
[TBL] [Abstract] [Full Text] [Related]
4. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
[TBL] [Abstract] [Full Text] [Related]
5. In Search of TGCT Biomarkers: A Comprehensive
Raos D; Krasic J; Masic S; Abramovic I; Coric M; Kruslin B; Katusic Bojanac A; Bulic-Jakus F; Jezek D; Ulamec M; Sincic N
Dis Markers; 2020; 2020():8841880. PubMed ID: 33224314
[TBL] [Abstract] [Full Text] [Related]
6. [Clinicopathologic features of testicular seminoma with syncytiotrophoblastic cells: Analysis of 3 cases and review of the literature].
Liang Y; Tu P; Wang X; Yi XM; Zhou XD; Shi QL
Zhonghua Nan Ke Xue; 2019 Jul; 25(7):642-646. PubMed ID: 32223107
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive characterization of cancer-testis genes in testicular germ cell tumor.
Chang Y; Wang X; Xu Y; Yang L; Qian Q; Ju S; Chen Y; Chen S; Qin N; Ma Z; Dai J; Ma H; Jin G; Zhang E; Wang C; Hu Z
Cancer Med; 2019 Jul; 8(7):3511-3519. PubMed ID: 31070303
[TBL] [Abstract] [Full Text] [Related]
8. [Secondary pseudopriapism after lymphatic invasion in a patient with adenocarcinoma of the rete testis].
Scott Pabon G; Fiter Gómez L; Manzano Peña MT
Rev Int Androl; 2019; 17(1):37-40. PubMed ID: 30691590
[TBL] [Abstract] [Full Text] [Related]
9. [Molecular Pathogenesis of testicular Germ Cell Tumors].
Bakardjieva-Mihaylova V; Škvárová Kramarzová K; Slámová M; Büchler T; Boublíková L
Klin Onkol; 2017; 30(6):412-419. PubMed ID: 29271211
[TBL] [Abstract] [Full Text] [Related]
10. [Clinicopathologic features and expression of OCT4 protein in testicular diffuse large B cell lymphoma].
Chen YP; Zhu WF; Chen LF; Lu JP; He TM; Fu WD; Xu CW; Chen G
Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):383-387. PubMed ID: 28591984
[No Abstract] [Full Text] [Related]
11. testicular germ cell tumor genomics.
Woldu SL; Amatruda JF; Bagrodia A
Curr Opin Urol; 2017 Jan; 27(1):41-47. PubMed ID: 27584029
[TBL] [Abstract] [Full Text] [Related]
12. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
[TBL] [Abstract] [Full Text] [Related]
13. [testicular malignant Leydig cell tumor: A case report].
Lu W; Zhang M; Wang SP; Wang X; Cai ZM
Zhonghua Nan Ke Xue; 2016 May; 22(5):442-5. PubMed ID: 27416670
[TBL] [Abstract] [Full Text] [Related]
14. Identification and characterization of 2 testicular germ cell markers, Glut3 and CyclinA2.
Howitt BE; Brooks JD; Jones S; Higgins JP
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):401-7. PubMed ID: 23343953
[TBL] [Abstract] [Full Text] [Related]
15. [Clinicopathologic analysis of spermatocytic seminoma].
Tian BL; Gao AF; Xu C; Chang XY; Xu ZQ; Su QH; Yang XH
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):752-5. PubMed ID: 23302336
[TBL] [Abstract] [Full Text] [Related]
16. Recurrent seminomas: clinical features and biologic implications.
Som A; Zhu R; Guo CC; Efstathiou E; Xiao L; Pisters LL; Matin A; Tu SM
Urol Oncol; 2012; 30(4):494-501. PubMed ID: 20822932
[TBL] [Abstract] [Full Text] [Related]
17. Expression of cd117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications.
Sever M; Jones TD; Roth LM; Karim FW; Zheng W; Michael H; Hattab EM; Emerson RE; Baldridge LA; Cheng L
Mod Pathol; 2005 Nov; 18(11):1411-6. PubMed ID: 16056250
[TBL] [Abstract] [Full Text] [Related]
18. Expression of HER-2/neu in testicular tumors.
Mandoky L; Geczi L; Bodrogi I; Toth J; Bak M
Anticancer Res; 2003; 23(4):3447-51. PubMed ID: 12926088
[TBL] [Abstract] [Full Text] [Related]
19. The future of therapy for nonseminomatous germ cell tumors.
Donadio AC; Bosl GJ
Chest Surg Clin N Am; 2002 Nov; 12(4):769-89. PubMed ID: 12471877
[TBL] [Abstract] [Full Text] [Related]
20. CD30 and cd117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma.
Leroy X; Augusto D; Leteurtre E; Gosselin B
J Histochem Cytochem; 2002 Feb; 50(2):283-5. PubMed ID: 11799147
[TBL] [Abstract] [Full Text] [Related]
